WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Hamilton mayor's Anzac trip to Belgium criticised amid massive rates riseFriends of Kiwi who died in Australia raising funds to bring body homeWhale song mystery solved by scientistsLandlord tax breaks will blow out by $1bWest Coast ratepayers must decide: 27% rates hike, or 44%?Alexei Navalny was about to be freed in prisoner swap, says colleagueDavid Cameron's Falklands visit prompts playful dig from Buenos AiresCommunity housing developments stall as government funding not guaranteedBanging sound from Titan submersible search heard for first time in UK documentaryHaiti gangs try to take over Port